During the past decade, Sparta Cancer Treatment Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 24 clinical trials were completed, i.e. on average, 600% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 10 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sparta Cancer Treatment Center" #1 sponsor was "National Cancer Institute (NCI)" with 20 trials, followed by "Radiation Therapy Oncology Group" with 5 trials sponsored, "NSABP Foundation Inc" with 4 trials sponsored, "SWOG Cancer Research Network" with 3 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sparta Cancer Treatment Center" #1 collaborator was "National Cancer Institute (NCI)" with 16 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator, "Radiation Therapy Oncology Group" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "North Central Cancer Treatment Group" with 4 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Sparta Cancer Treatment Center" are "Breast Cancer" (6 trials), "Breast Adenocarcinoma" (3 trials), "Prostate Cancer" (3 trials), "Adult Glioblastoma" (2 trials) and "Adult Gliosarcoma" (2 trials). Many other conditions were trialed in "Sparta Cancer Treatment Center" in a lesser frequency.

Most popular intervention types in "Sparta Cancer Treatment Center" are "Drug" (35 trials), "Other" (21 trials), "Radiation" (19 trials), "Biological" (18 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (18 trials), "Quality-of-Life Assessment" (11 trials), "Paclitaxel" (8 trials), "Bevacizumab" (7 trials) and "Cisplatin" (6 trials). Other intervention names were less common.

The vast majority of trials in "Sparta Cancer Treatment Center" are 28 trials for "All" genders, 11 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Sparta Cancer Treatment Center". undefined are not yet recruiting, 4 are recruiting, 22 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Sparta Cancer Treatment Center, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Sparta Cancer Treatment Center, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".